THE NEUTRAL ZONE
The U.S. reached a significant milestone in the battle with coronavirus Monday as the total number of those vaccinated eclipsed the total number of people who tested positive. Data from Johns Hopkins University shows that 26.3 million people tested positive for COVID-19 since the U.S. began tracking cases, and now 26.5 million Americans have received at least one dose of the available vaccines. The U.S. is administering about 1.34 million vaccines a day, which is a higher rate than any other country in the world.
Other countries outside the U.S. are having success as well. Israel’s vaccination rollout was linked to a drop in coronavirus cases for people older than 60. South Africa has also rolled out its first vaccine doses, which consist of one million AstraZeneca jabs produced by the Serum Institute of India. South African front-line healthcare workers preparing to begin vaccinations in two weeks will be the ones to receive the first doses. Russia has also announced that its Sputnik V vaccine is 91.6% effective against symptomatic COVID-19 per Phase 3 trial findings. Sputnik V has been distributed to around two million people in several countries, all before the Phase 3 trial had confirmed the drug’s efficacy.
This section includes an aggregation of articles showing different viewpoints on the topic.
Coronavirus latest: US vaccinations surpass total number of cases – as it happened – Financial Times – 2/2/2021
The latest figures from the Covid Tracking Project show that the US has had 25.8m confirmed cases of coronavirus. The US tallied 118,780 new cases on Sunday, the lowest mark since November 9. Hospitalisations have also fallen, hitting a level last seen in late November and reflecting declining trends following a resurgence of the virus that impacted most of the country.
Moderna Could Boost Vaccine Supply by Adding Doses to Vials – New York Times – 2/1/2021
Moderna is hoping to raise the number of doses in its vials to as many as 15 from the current 10 doses. The proposal reflects the fact that the company has been ramping up production of its vaccine to the point where the final manufacturing stage, when it is bottled, capped and labeled, has emerged as a roadblock to expanding its distribution.
Live updates: Russian vaccine over 91% effective against coronavirus, peer-reviewed test results show – Washington Post – 2/2/2021
In the first publicly available test results for Russia’s already widely distributed vaccine, Sputnik V, it was shown to be 91.6 percent effective against the coronavirus in Phase 3 trials, according to peer-reviewed results published in the Lancet, a British medical journal. The findings make Sputnik only the third vaccine to have an efficacy of over 90 percent after a vaccine from U.S. pharmaceutical giant Pfizer, produced with German biotech firm BioNTech, and one from U.S. biotech firm Moderna.
This section includes an aggregation of tweets showing different viewpoints on the topic.